NewsRx

Search our medical news database

Endocrinology

Company acquires new peptide to increase its diabetes portfolio

Published in Obesity and Diabetes Week, February 17th, 2003

Theratechnologies (TSX:TH) announced the signing of an agreement that provides the company all commercial rights to a peptide that could have applications in diabetes.

The peptide was discovered jointly by Dr. A.J. van der Lely, of the Erasmus Medical Center of Rotterdam in the Netherlands, and Dr. Ezio Ghigo, with University of Turin in Italy. The research and assignment agreement was signed with the discoverers and their affiliated institutions.

The company has filed an international patent application for the compound and thus will hold full rights to its intellectual property.

"Our objective is to build a strong and focused...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook